The human MET gene imparts a replicated risk for autism spectrum disorder (ASD), and is implicated in the structural and functional integrity of brain. MET encodes a receptor tyrosine kinase, MET, which has a pleiotropic role in embryogenesis and modifies a large number of neurodevelopmental events. Very little is known, however, on how MET signaling engages distinct cellular events to collectively affect brain development in ASD-relevant disease domains. Here, we show that MET protein expression is dynamically regulated and compartmentalized in developing neurons. MET is heavily expressed in neuronal growth cones at early developmental stages and its activation engages small GTPase Cdc42 to promote neuronal growth, dendritic arborization and spine formation. Genetic ablation of MET signaling in mouse dorsal pallium leads to altered neuronal morphology indicative of early functional maturation. In contrast, prolonged activation of MET represses the formation and functional maturation of glutamatergic synapses. Moreover, manipulating MET signaling levels in vivo in the developing prefrontal projection neurons disrupts the local circuit connectivity made onto these neurons. Therefore, normal time-delimited MET signaling is critical in regulating the timing of neuronal growth, glutamatergic synapse maturation and cortical circuit function. Dysregulated MET signaling may lead to pathological changes in forebrain maturation and connectivity, and thus contribute to the emergence of neurological symptoms associated with ASD.
INTRODUCTION
Normal brain development is dictated by a plethora of growth factors and their receptor protein tyrosine kinases. 1 Molecular signaling via MET receptor tyrosine kinase (RTK), and its ligand hepatocyte growth factor (HGF), has a pleiotropic role in the ontogenesis of multiple organs. 2, 3 MET and HGF are also expressed in the developing nervous system of rodents, monkeys and humans, [4] [5] [6] [7] and are known to mediate a multitude of neurodevelopmental events including neural induction, 8 neurotrophic and chemotrophic effects of developing axons, 6, 9 and motogenic effects of specialized central neuron populations. 10 Further corroborating its pleiotropic role in the nervous system, MET signaling also promotes neuronal survival, 11, 12 and facilitates development of neuronal dendritic morphology under in vitro cultured conditions. 13 The human MET gene is a well-established risk factor for autism spectrum disorder (ASD), [14] [15] [16] [17] a highly heritable psychiatric condition defined by disrupted ontogeny of neural connectivity. 18 Notably, a non-coding promoter variant of the human MET gene, the rs1858830 'C' allele, which reduces MET transcription and protein translation, is associated with increased ASD risk.
14, 15 The role of MET in autism etiology is further supported by its selective expression in brain structures involved in higher levels of cognition, social and language skills, and executive functions. 4, 7 In addition, human MET gene transcription can be regulated by FOXP2 and MeCP2, 7, 19 factors known to affect ASD-related circuits development in humans. 20, 21 The rs1858830 'C' risk allele also predicts atypical functional magnetic resonance imaging activation and deactivation patterns of the human brain to social stimuli, and is correlated with reduced structural and functional connectivity in temporoparietal lobes, 22 areas known to selectively express MET. 4 Therefore, existing literature strongly suggests that MET signaling converges on cellular substrates relevant to ASD etiology.
Importantly, MET expression is tightly regulated at both spatial and temporal domains of the developing brain. Peak levels of MET expression in mice and monkeys coincide with a period of rapid postnatal neuronal growth and synaptogenesis, 4, 5 but undergo precipitous downregulation during synapse pruning and maturation stage. Currently, the functional significance of this timedelimited signaling is largely unknown. Whether downregulation of MET expression is required for further development of glutamatergic synapse and refinement of circuit connections is an intriguing and open question. We and others have previously shown that in forebrain-specific Met conditional knockout mice, MET loss-of-function results in a region-and cell type-specific alterations in neuronal structure 5 and synaptic function. 23, 24 In this study, we hypothesized that MET is capable of profoundly shaping neural morphology development and glutamatergic synapse formation, particularly in MET-expressing brain structures involved in higher cognitive function. We tested this hypothesis by investigating how altered MET signaling impacts the developmental trajectory of neuronal growth, maturation and synaptic connectivity in the mouse forebrain in search for a potential biological underpinning of the ASD risk conferred by MET.
MATERIALS AND METHODS
A detailed description can be found in Supplementary Information.
Mice
C57Bl6 mice were used for embryonic primary neuron cultures, prefrontal cortex (PFC) slice cultures and in utero electroporation (IUEP) studies. The day of vaginal plug detection was designated as E0.5 and the day of birth as P0. Dorsal pallial-specific conditional Met mutant mice (Met fx/fx ; Emx1 cre , 'cKO') were generated and genotyped using previously described protocols. 5 In this model, cre-mediated excision of Met exon 16 leads to a loss-of-function 'kinase-dead' MET protein 25 ( Figure 3a) . For all studies, samples were coded so that the experimenter was blind to genotype. All procedures using mice were approved by the Institutional Animal Care and Use Committees of University of Southern California and the University of Arizona and conformed to NIH guidelines.
DNA constructs, neuronal transfection and IUEP
Met cDNA vector that expresses the full open reading frame of the mice Met gene (NM_008591), the RNA interference (RNAi) construct for Met, and their validity has been reported. 24 Cdc42 RNAi sequence (GCAGTCACAGTT ATGATTG) was cloned into pSuper and verified by co-transfection with Cdc42 cDNA in HEK293 cells (data not shown). Dominant negative Cdc42 (Cdc42-N17) was from D. Webb (Vanderbilt University). We co-transfected plasmids with pEGFP-C3 (GFP) vector using calcium phosphate precipitation method. 24 To target the developing layer 5 (L5) PFC neurons in vivo, IUEP experiments were carried out using time-pregnant mice at E13.5, similar to a previous report. 26 The embryos' right prefrontal region was targeted for electroporation. The offspring that underwent IUEP were collected for electrophysiology recording and laser scanning photostimulation (LSPS) mapping studies at post natal (P) 23-25. Primary neuron culture and PFC slice cultures Cortical or hippocampal neuron cultures were prepared from embryonic day E16.5 time-pregnant C57BL/6 mice and grown on 12 mm glass coverslips at low densities (~10,000 cells mm −2 ), as described previously. 24 Neurons were collected at day in vitro (DIV) 5-28 for immunocytochemistry (ICC) labeling or electrophysiology recording. For organotypic cultures of cortical slices containing PFC, postnatal day 6-7 C57Bl6 mouse brains were sliced into 250 μm-thick sagittal sections using a vibratome (Leica V-1200 S) under sterilized conditions. Slices were cultured on Millicell cell culture inserts (Millipore, Billerica, MA, USA) in Dulbecco's Modified Eagle Medium/F12 medium supplemented with 10% fetal bovine serum. HGF (50 ng ml − 1 , Millipore) was added at 14 day in culture where necessary. Patch-clamp recordings on L5 PFC neurons were conducted at day 22-25. Growth cone fraction isolation, biochemistry, western blot and ICC We isolated growth cone-enriched fraction of postnatal day 0 mouse cortices using the methods reported by Pfenninger et al. 27 ( Figure 1f , Supplementary Information). Western blot analysis of tissue/cells and ICC staining were performed and quantified using standard methods. 24 We micro-dissected PFC and hippocampus regions in brain slices and homogenized the tissues in cold NP40 cell lysis buffer (FNN0021, Life Technologies, Carlsbad, CA, USA) supplemented 1:50 protease inhibitor cocktail (Sigma, St Louis, MO, USA P8340) and 1 mM phenylmethylsulfonyl fluoride. Total proteins were quantified using a micro-bicinchoninic acid assay (Pierce, Rockford, IL, USA). Sample proteins were separated on 9% SDS-polyacrylamide gels, transferred to polyvinylidene fluoride membranes (Immobilon-P, Millipore), incubated with primary antibodies overnight at 4°C, and followed by incubation with horseradish peroxidase-conjugated secondary antibodies (Promega, Madison, WI, USA) for 2 h at room temperature. Enhanced chemiluminescence method (ECL Plus, GE Healthcare, Pittsburgh, PA, USA) was used to quantify the signal. Optical density of immunoreactive bands was quantified by densitometry using Image J. All antibodies and their sources are listed on Supplementary Information.
To probe activated (GTP-bound) Cdc42, we used a Cdc42 activation assay kit (Millipore, 17-441) according to the manufacturer's directions.
Acute PFC slice preparation, drug treatment, patch-clamp whole-cell recording To test the signaling competency of MET protein in the developing mouse brain, we adopted an ex vivo live brain slice preparation. Acute sagittal brain slices at postnatal day 9-10 containing PFC were sliced and kept alive in artificial cerebrospinal fluid. Slices were treated with HGF (50 ng ml − 1 , 30 min) at 35°C with or without MET kinase inhibitors PHA665752 or SU11274, or PI3K inhibitors Wortmanin or LY294002. PFC tissues from these slices were then dissected, and subjected to western blot analysis or small GTPase activation assay.
Miniature excitatory postsynaptic currents (mEPSCs) were recorded in cultured cortical neurons and L5 PFC neurons in cultured slices using whole-cell patch-clamp technique. Neurons or slices were perfused with artificial cerebrospinal fluid containing (in mM), 126 NaCl, 2. 
LSPS for cortical circuit mapping
For LSPS mapping of prefrontal circuits, essentially the same protocol was reported previously 23, 28 (Supplementary Information). Pups born to IUEP dams were killed at P23-25. Sagittal slices containing the right PFC were made. Individual GFP-expressing PFC L5 neurons were selected for patchclamp recording and LSPS mapping based on anatomical landmarks delineated by the online Allen Brain Atlas (prelimbic area, layer 5). Slices were perfused in modified artificial cerebrospinal fluid (4 mM Ca 2+ , 4 mM Mg 2+ ), with 0.2 mM 4-methoxy-7-nitroindolinyl-caged glutamate and 5 μM 3-(R-2-Carboxypiperazin-4-yl)-propyl-1-phosphonic acid. Electrophysiological signals were amplified with a Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA) and acquired with BNC 6259 data acquisition boards (National Instruments, Austin, TX, USA) under control of Ephus software (http://www.ephus.org). Signals were digitized and acquired at 10 kHz. LSPS mapping on slices was performed at room temperature in a customized recording chamber mounted on a motorized stage (Sutter MPC-78, Novato, CA, USA). Neuronal soma selected for recording was at least 50 μm below the slice surface to minimize truncation of dendritic structures. LSPS mapping combined with glutamate uncaging were performed with a × 4 objective lens (NA 0.8; Olympus) and 20 mW, 1-ms UV laser (355 nm; DPSS Lasers) pulses. Digital images and stimulation locations were registered using a CCD camera (Retiga 2000DC, Qimaging, Surrey, BC, Canada). Neuronal responses to laser uncaging/mapping were analyzed offline with custom Matlab routines.
Neuronal morphological analysis
In some experiments, a rapid Golgi staining kit (FD Neurotechnologies, Columbia, MD, USA) was used to reveal neuronal dendritic morphology. P35-38 brains were fixed for 10-12 days, sectioned into 250 μm slices, and further processed according to the manufacturer's protocol. Dendritic arbors were traced using Neurolucida (MicroBrightField, Williston, VT, USA). Morphometric parameters were extracted using Neurolucida explorer, similar to that described previously. 29 To reconstruct spines in PFC L5 corticostriatal (CS) or CA1 neurons from Met cKO mice and their littermate controls, we used biocytin injection to reveal morphology. For CS neurons, we first injected 50 nl retrograde red fluorescent latex microspheres ('beads', Lumafluor, Durham, NC, USA) into left dorsal striatum, then prepared the right PFC slice at 24 h or later. L5 beads-positive CS neurons were dialyzed (500 pA holding current for 10 min) with 1% biocytin Role of MET RTK in neural development and circuit function Y Peng et al dissolved in the potassium-based internal electrode solution. Slices were then fixed by 4% paraformaldehyde overnight followed by avidin-Alexa488 (Life Technologies) conjugation for 24 h. Confocal Z stacks were acquired from secondary apical branches 150-200 μm away from soma using a Zeiss 710 microscope (×63 oil objective, NA 1.4, with × 2 digital zoom). We used Imaris software (Bitplane, V7.01, Concord, MA, USA) to measure spine parameters and classify them into 'filopodia', 'stubby', 'mushroom' and 'long thin' categories using Imaris default spine classification module. 30 
Statistical analysis
Quantitative results were expressed as mean ± s.e.m. Data were processed using Microsoft Excel, Matlab and GraphPad Prism 5.0. Sample size was estimated by power analysis using an R script that takes pre-specified effect size, type I and II errors as input arguments. The same algorithm was used to estimate sample size of mice. Student's t-test or one-way/ two-way analysis of variance (ANOVA) was used when data passed normality test. Potential data outliers were identified as those differ at least three s.d's from the mean and excluded from analysis where applicable.
For IUEP experiments, mice were grouped randomly. Sample size n represents number of independent treatments obtained from at least three mice. Kolmogorov-Smirnov (K-S) test was used to compare cumulative distribution of mEPSC amplitude and inter-event intervals. Spine head size (non-normal distribution) comparison was made using non-parametric Mann-Whitney test. Dunnett's multiple comparisons or Bonferroni post hoc test was used for between-group comparisons after ANOVA revealed overall significance. Po0.05 was considered statistically significant. 
RESULTS

Developmental MET expression in mouse forebrain and sub-cellular localization in growth cones
The developing mouse forebrain is known to transiently express MET. 5 We started by probing the levels of the MET protein and its putative molecular signaling constituents across multiple prenatal and postnatal developmental stages. We focused on two forebrain regions, the PFC and the hippocampus, areas implicated in psychiatric conditions of developmental origin. 31 Immunohistochemistry labeling using specific MET antibody (sc-8057) revealed strong MET immunoreactivity at P14 in both PFC and hippocampus ( Figure 1a) . Next, protein samples were collected from PFC and hippocampus in live brain slices at embryonic day (E) 17.5 and postnatal days (P) 3, 11 and 21 to probe MET levels using western blot. MET protein expression in both PFC and hippocampus peaks during P3 to P11, and significantly declines by P21 (Figures 1a and b, n = 3). MET ligand, HGF, and other proteins implicated in MET signaling pathway, including adaptor proteins Gab1 and Grb2, potential downstream signaling molecules PI3K, small GTPases Cdc42 and Rac1 are all abundantly expressed in PFC tissue across E17.5-P21 (Figure 1c , n = 2, quantification not shown). The temporal regulation of MET expression seems to be cell autonomous, as western blot analysis and ICC staining of primary cultured hippocampal neurons also displayed a similar temporally regulated expression pattern (Figure 1d) .
Importantly, confocal imaging revealed strong MET immunoreactivity at the tip of growth cones (Figure 1e ), indicating METmediated signaling may be functionally coupled with molecular machinery operating at the growth cone, and may account for HGF-stimulated neuronal growth. 13 To further confirm this subcellular distribution of MET during early neuronal growth stage, we prepared growth cone fractions from P0 mouse cortex (Figure 1f ), 27 and found MET protein is indeed enriched in the growth cone fraction, along with other known growth coneenriched proteins (p-Tau, GAP43, Cdc42 and FAK; Figure 1g ). We therefore hypothesize that the growth cone localization of MET is indicative for a functional role in mediating early neuronal growth.
MET-induced neuronal growth effects depend on its kinase activity and downstream activation of small GTPase Cdc42 In epithelial cells, MET is known to signal through adaptor proteins leading to an activation of small GTPases, including Rap1, and Rho family small GTPases RhoA, Cdc42 and Rac1, which are responsible for the formation of filopodia and lamellipodia. [32] [33] [34] In neurons, activation of Rho family small GTPases, such as Cdc42, is critical for dendritic and spine morphogenesis, axon growth and motility. 35, 36 We hypothesized that Rho family small GTPases may be activated and mediate MET effects on early neuronal growth. We first tested the competency of MET signaling in an ex vivo brain slice preparation, utilizing the endogenous MET and its native signaling components. Acute live PFC slices were prepared from P9-10 mice and treated with HGF (50 ng ml − 1 , 30 min) or saline ( Figure 2a ). We found HGF induces tyrosine phosphorylation of MET at Y1234/1235, an event that is critical in mediating MET-induced growth in peripheral cell types.
2 HGF-induced pY1234/1235 can be partially antagonized by 200 nM PHA665752, an MET kinase activity inhibitor (Figure 2b ), but cannot be blocked by 100 nM Wortmanin, a PI3K inhibitor (Figure 2c ). We next tested whether the Rho family small GTPases are activated in neurons. Both ex vivo P9-10 PFC slices (n = 4) and in vitro cultured cortical neurons (DIV11, n = 3) were treated with HGF (50 ng ml − 1 , 30 min), and probed for activated, GTP-bound form of Cdc42 (see Materials and Methods). We consistently observed a dramatic increase in Cdc42-GTP (Figure 2d ). These results for the first time revealed the involvement of small GTPases following MET activation in neurons. Furthermore, Cdc42 activation depends on both MET kinase activity and PI3K function, as both PHA665752 (200 nM) and Wortmanin (100 nM) blocks the increase of Cdc42-GTP following HGF treatment (Figure 2e , n = 4). To overcome the potential issue of specificity of kinase inhibitors, we also tested another MET inhibitor SU11274 (10, 50 nM) and PI3K inhibitor LY294002 (5, 20 μM) on HGF-induced Cdc42 activation. Both of these inhibitors reduced Cdc42-GTP in a dose-dependent manner (Supplementary Figure S1) .
Previous studies indicate that MET affects neuronal growth, dendritic and spine morphology development.
13, 24 We next tested whether Cdc42 mediates some of these effects. Cultured cortical neurons at DIV11 were transfected with Met cDNA or in combination with a dominant negative form of Cdc42 (T17N, DN-Cdc42), or Cdc42 interference RNA (Cdc42 RNAi) to knockdown endogenous Cdc42. GFP vector was co-transfected to reveal morphology. Quantification of neuronal morphology was done at DIV25 (Figure 2f ). We quantified total dendritic branch tip number (TDBTN), total dendritic branch length (TDBL) and spine density for each group. 37 We found that Met cDNA overexpression (MET OE) significantly increased TDBTN (F (4,56) = 10.73; P o0.001, oneway ANOVA with Dunnett's post hoc test), an effect that was significantly blocked by co-transfection with DN-Cdc42 or Cdc42 RNAi (Figure 2g) . Notably, Cdc42 RNAi alone significantly reduced TDBTN (P o0.05), underscoring the importance of Cdc42 in dendritic morphology development. 38 Similar conclusion was obtained when neurons were quantified using TDBL (F (4,56) = 12.01; P o 0.001; Figure 2h ). In addition, we found MET OE significantly increased dendritic spine density (F (4,60) = 15.4; Po 0.001), an effect that was also significantly blocked by DNCdc42 or Cdc42 RNAi (Figure 2i ). Further corroborating these findings, MET RNAi-induced reduction of dendritic length and spine density was reversed by elevated Cdc42 activity, as a constitutive active form of Cdc42(V12) 38 completely antagonized MET effect (Supplementary Figure S2) . Taken together, these results reveal a novel molecular mechanism involving Cdc42 downstream to MET signaling that mediates MET effect on dendritic and spine development. Dorsal pallial-specific conditional knockout of MET impacts neuronal morphology development Previous studies show that MET is expressed by discrete subtypes of long-projecting neurons of the forebrain, including the PFC and the hippocampus CA1. 4, 5 We next investigated the effect of MET loss-of-function on neuronal morphology during in vivo development using a dorsal pallial-specific Met conditional knockout (cKO) mice model (Met fx/fx ; Emx1 cre ; see Materials and Methods).
5
Consistent with MET loss-of-function in cKO and the role of Cdc42 in mediating MET effects, HGF activation in P10 cKO slices did not lead to Cdc42 activation compared with its effects in Met fx/ fx control slices (Figure 3a , n = 2). We next conducted a detailed morphological investigation on the projection neurons in Golgistained brain sections from juvenile (P35-38) cKO mice and their Met fx/fx littermate controls. We selected PFC L5 neurons and CA1 neurons for morphological reconstruction (Figure 3b ). Sholl analysis 39 revealed an overall significant reduction of dendritic length at both apical and basal dendritic structure in cKO PFC L5 neurons (Figure 3c , n = 7-8 neurons for each genotype; F (1,288) = 19.1 for the genotype effect; P o 0.001). For CA1 neurons, although no significant genotype effects was observed (F (1,315) = 0.003) on the overall dendritic length, dendritic branching pattern was significantly altered in cKO. We also observed a significant reduction in the dendritic spine density in cKO neurons, quantified in secondary branches located 100-200 μm from soma (P o 0.05, for both PFC L5 and CA1 neurons, Student's t-test).
Because Golgi staining underestimates spine density, and is incapable of measuring spine size quantitatively, 40 we used biocytin to fill PFC L5 and CA1 neurons, followed by avidinAlexa488 to reveal fine spine morphology. To ensure the same neuronal type is selected for comparison, we injected red fluorescent 'beads' 23 in contralateral dorsal striatum to label the crossing CS neurons, and then selected beads-positive L5 CS neurons for spine morphology studies using Imaris reconstruction from confocal Z stack images (Figure 3d ). Quantitative analysis revealed that cKO neurons exhibited significantly reduced spine density (Figure 3e ; 13.4 ± 0.5 spines per 10 μm dendrite, compared with 15.3 ± 0.7 in Met fx/fx control; t 20 = 2.27; P o0.05) and enlarged spine head volume (Figure 3f ; P o 0.01). In cKO, significantly fewer spines on L5 CS neurons falls into classification of 'filopodia' (1.21 ± 0.21 vs 2.35 ± 0.40 spines per 10 μm dendrite; Po 0.05), 'stubby' (2.68 ± 0.41 vs 4.21 ± 0.56; Po 0.05) and 'long thin' (2.38 ± 0.13 vs 3.35 ± 0.21; P o0.05); whereas more spines are classified into 'mushroom' type (7.32 ± 0.44 vs 5.21 ± 0.48; P o 0.01; Figure 3g ), which are putative mature type of spines. 41 Next, we analyzed CA1 pyramidal neurons (Figure 3h) , and found that spine density in cKO neurons is lower overall (Figure 3i; 13.2 ± 0.61 spines per 10 μm dendrite, compared with 15.7 ± 0.9 in Met fx/fx controls; Po 0.05). Similar to L5 CS neurons, we found that spine head volume in CA1 neurons is significantly enlarged (Figure 3j ; P o 0.01). A significant increase in mature 'mushroom' type spine density (7.58 ± 0.55 vs 5.21 ± 0.30; P o0.01) and a decrease in immature 'stubby' type spines (2.13 ± 0.16 vs 4.26 ± 0.38; P o0.01) were observed in cKO neurons (Figure 3k ).
These morphology results indicate enlarged spine size at two major forebrain structures following MET loss-of-function. Considering that spine size and geometry are highly correlated with glutamatergic synapse function, 42 these results strongly implicate altered synaptic function in these two forebrain structures at the development stage examined.
Prolonged MET signaling represses glutamatergic synapse formation and functional maturation MET protein expression levels are tightly regulated across the temporal domain during forebrain development, with peak expression coinciding with the principal periods of neurite outgrowth and synaptogenesis, followed by rapid downregulation thereafter 5 ( Figure 1 ). The functional significance of downregulation is not clear. We prolonged MET signaling by adding HGF during a period when MET protein is undergoing downregulation. We tested this prolonged HGF effect on synapse formation in cultured cortical neurons and cortical slices containing the PFC region. HGF (50 ng ml − 1 ) was added to cultured cortical neuron at DIV14. We then used ICC to label two pairs of excitatory synapse markers (synapsin I+PSD95; GluN1+GluA1) at DIV25. Each protein marker produced discrete punctate labeling, potentially reflecting a synaptic site. Putative functional synapses are represented by ) induces Cdc42 activation, measured by PAK P21 domain pull-down of the GTP-bound Cdc42. In contrast, no change of overall Cdc42 level was observed (*P o0.05, **P o0.01). (e) Cdc42 activation was blocked by either PHA665752 or Wortmanin, indicating it is dependent on MET kinase activity and downstream to PI3K activation (**Po 0.01). (f) Neuronal morphometric measurement using total dendritic branch tip number (TDBTN) and total dendritic branch length (TDBL), and representative images of dendritic and spine morphology from cultured neurons transfected with Met cDNA, or in combination with Cdc42 loss-of-function plasmids (DN-Cdc42 or Cdc42 RNAi). (g) TDBTN quantification (normalized to GFP control neurons) reveals MET OE significantly increased TDBTN, which is significantly blocked by either DN-Cdc42 or Cdc42 RNAi cotransfection. Note Cdc42 RNAi alone significantly reduced TDBTN (*P o0.05, **Po0.01 compared with GFP, NS, not significant. ## Po 0.01. Number of neurons quantified listed on bar). (h) MET OE increases TDBL, an effect that is also blocked by co-transfection with DN-Cdc42 or Cdc42 RNAi (*Po 0.05, **P o0.01, Figure 4c ; Po 0.001, t-test). A similar conclusion was made when synapse density was quantified using GluN1/GluA1 co-labeling. HGF treatment significantly reduces the puncta density of GluA1 (Figure 4d ; saline, 7.18 ± 0.33; HGF, 5.12 ± 0.44; P o 0.01), without ), inactivates the intracellular tyrosine kinase activity of MET and abrogates adaptor protein recruitment and downstream signaling. Consistently, HGF treatment in cKO prefrontal cortex (PFC) slices failed to induce an increase in pY1234/1235 (n = 2, quantification not shown). (b) Photomicrograph of Golgi-stained prefrontal (infra-limbic) L5 pyramidal neuron, and hippocampus CA1 neuron in Met fx/fx and cKO brains. A representative dendritic arbor reconstructed in 3D using Neurolucida for each neuron was shown on the right, and dendritic segments from which dendritic spine density was calculated were shown below the image. (c) Sholl analysis of PFC L5 and hippocampal CA1 neuron dendritic complexity. A significant reduction of dendritic length was found in PFC L5 (two-way analysis of variance with Bonferroni post hoc test, F (1,288) = 19.06. n = 7 neurons/3 mice for Met fx/fx and n = 8/4 for cKO. *P o0.05). No significant overall difference was found for CA1 neurons (F (1,315) = 0.003. n = 8 neurons/3 mice for Met fx/fx and n = 9/3 for cKO), while dendritic length was distributed differently (*Po0.05). Dendritic spine density showed a significant reduction in both prefrontal L5 pyramidal neuron and CA1 pyramidal neuron in cKO brains (*Po 0.05, t-test). (d) Dendritic spine morphology in P35 PFC L5 corticostriatal neurons, labeled by red retrograde 'beads', was reconstructed using Imaris and high-resolution confocal Z stack images. (e) Met cKO PFC L5 neurons showed a significant reduction in spine density (*Po 0.05). (f) Dendritic spine head volume in cKO PFC L5 neurons is significantly larger (**Po0.01). (g) Dendritic spines from cKO PFC L5 neurons show significantly increased number in 'mushroom' type (**P o0.01), while significant decreased numbers in all other categories (*Po 0.05). Numbers labeled on bar denotes number of neurons, based on which 4500 spines were analyzed for each group. (h) Morphological reconstruction of CA1 neuron spines. (i and j) CA1 neurons from cKO mice show a significant reduction in spine density (i, t 16 = 3.42, *P o0.05), and a significant increase in dendritic spine head volume (j, **P o0.01). (k) CA1 neuron dendritic spines from cKO mice show significant increased number in 'mushroom' type (**Po0.01), and significant decreased numbers in the 'stubby' category (**Po 0.01).
altering the density of GluN1 labeling. Functional synapse defined by co-labeling of GluN1/GluA1 was also significantly lower in HGFtreated neurons (21.3 ± 1.2%) compared with saline-treated control neurons (33.5 ± 2.2%; Figure 4e ; P o 0.001, t-test). This reduced functional synapse was consistent with electrophysiological findings from these neurons ( Figure 4f) ; compared with saline-treated neurons, mEPSCs from neurons with prolonged HGF treatment were generally of smaller amplitude (Figure 4g ; P o0.01) and longer inter-event intervals (Figure 4h ; P o 0.05).
We next prepared cultures of organotypic brain slices containing the PFC region from P6-7 mice. This preparation has the advantage of preserving the local three-dimensional structure of native neuron types and the laminar connections within and between cortical layers, 43 which allows us to test the development of synaptic properties in intact cortical circuits by stimulating L2/3 and recording in the synaptically connected L5 neurons (Figure 4i ). HGF (50 ng ml − 1 ) was added in the treatment group at DIV14, and experiments were carried out at DIV22-25. This treatment increases MET pY1234/1235 signal when measured at DIV22 (Figure 4j ), suggesting elevated MET signaling persists the duration of HGF application. Analysis of the mEPSC recorded from L5 PFC neurons (Figure 4k ) revealed that HGF significantly reduced the mEPSC amplitude (P o 0.001) and frequency (P o 0.01) compared with saline-treated neurons. We next used whole cell patch clamp to record AMPA/NMDA receptor current ratio (A:N) by stimulating L2/3 and obtaining a monosynaptic response in L5 neurons. We found that A:N ratio is significantly reduced in HGF-treated cells (HGF, 1.05 ± 0.15; saline, 1.58 ± .23; t 20 = 2.10; P o0.05; Figure 4l ). The functional maturation of cortical circuits also entails NMDA subunit switching, with GluN2A + puncta density (t 17 = 3.79; **P o0.01). (e) HGF also significantly reduced the proportion of putative functional synapse number, defined by GluN1 + /GluA1 + puncta (t 19 = 5.20; ***P o0.001). (f) Representative mEPSC recording from a control (saline) and HGF-treated neuron. Below, averaged mEPSC from a 1-min epoch was superimposed for comparison. (g) Compared with saline-treated neurons, HGF-treated neurons displayed significantly reduced mEPSC amplitude distribution (n42500 events/6 neurons for both groups; **P o0.01, K-S test) and increased inter-event intervals (h, n42000 events/8 neurons; *P o0.05, K-S test). (i) Illustration of cultured brain slices containing the PFC region, with a L5 neuron targeted for whole cell patch-clamp recording, and L2/3 was electrically stimulated to obtain monosynaptic responses. (j) HGF treatment for in cultured slices leads to prolonged MET activation, measured by increased pY1234/1235 (n = 2, quantification not shown). (k) Representative mEPSC recording from a L5 PFC neuron in control (saline) and HGF-treated cultured slices. Quantification reveals that HGF treatment significantly reduced mEPSC amplitude (n43000 events/9 neurons for each group; ***P o0.001, K-S test) and frequency (t 19 = 3.35; **P o0.01). (l) HGF-treated L5 neurons showed significantly reduced A:N current ratio (*P o0.05) compared with saline-treated control neurons. (m) HGF-treated L5 neurons showed significantly increased blockade of NMDAR current by ifenprodil (t 13 = 4.10; **P o0.01) compared with saline-treated control neurons.
gradually replacing GluN2B. 44 We quantified synaptic NMDAR currents contributed by GluN2B by probing sensitivity of NMDAR-EPSC to ifenprodil (3 μM), a GluN2B-selective antagonist. 45 We found that ifenprodil caused a 52.6 ± 4.4% reduction in NMDARmediated charge transfer in HGF-treated L5 PFC neurons, which is significantly higher than that from saline-treated L5 cells (31.4 ± 2.4%, P o 0.01; Figure 4m ). These results, together with decreased A:N ratio and mEPSC amplitude and frequency, and reduced functional synapse proportions following HGF treatment, strongly argue that prolonged MET signaling represses glutamatergic synapse maturation.
Single neuron gain-or loss-of-function of MET alters intra-cortical circuit connectivity On the basis of the significant effects observed on neuron morphology, we next asked whether altering MET signaling in single neurons during normal in vivo development leads to cellautonomous changes in local cortical network connectivity. IUEP was used to deliver MET OE or RNAi manipulations with GFP to the developing L5 neurons in the right frontal lobe of E13.5 mouse embryos (Supplementary Information). P23-25 mice offspring were selected for electrophysiology and LSPS mapping studies in L5 projection neurons (Figure 5a ). We found that neither MET OE nor RNAi significantly altered L5 neuron membrane properties (Supplementary Figure S3) . We next used LSPS mapping 23, 28 to quantify both excitatory and inhibitory synaptic inputs made onto these L5 neurons. As expected, L5 PFC neurons receive primary excitatory synaptic inputs from L2/3, and inhibitory synaptic inputs from local sources adjacent to the recorded neuron soma (Figures 5b-d , recorded from a L5 PFC neuron IUEP with GFP). Multiple excitatory and inhibitory LSPS maps from at least five mice were collected from MET OE, RNAi or GFP control neurons. Analysis of pooled maps (Figures 5e-i) revealed that compared with GFP control neurons, MET OE neurons received significantly increased L2/3 excitatory synaptic inputs (Figures 5f and h ; Po 0.05 for the MET OE effect); whereas RNAi neurons displayed a pronounced reduction in L2/3 synaptic drive (Figures 5g and h ; Po 0.05 for MET knockdown effects). Strikingly, the increased synaptic connectivity onto MET OE neurons primarily came from L5 (Figures 5f and h; P o 0.01; Bonferroni post hoc test), which is not a significant synaptic input source to L5 neurons in the anterior frontal cortex under normal development conditions 23 or in control neurons IUEP with GFP ( Figure 5e ). We next analyzed local inhibitory synaptic inputs onto these L5 MET OE, RNAi and GFP neurons. We did not detect significant treatment effects on the overall inhibitory inputs onto these neurons (Figure 5i ; P40.05). Therefore, single neuron manipulations in MET signaling during in vivo development are capable of disrupting local excitatory synaptic circuits without altering inhibitory connectivity.
DISCUSSION
Functional variants of human MET gene have been linked to differential ASD risks, but the underlying mechanism connecting genetic susceptibility and disease phenotype is not established. In this study, we investigated the role of MET RTK in neural development and circuit function. The major findings of our study are as follows. First, we ascertain the temporal expression patterns of MET protein in two mice forebrain regions relevant to autism pathogenesis, and uncover that MET is concentrated in a sub-cellular domain (growth cone) conducive to early neuronal growth. Second, we show that MET signaling leads to activation of small GTPase Cdc42, which accounts for aspects of MET-induced neuronal growth and dendritic morphology development. Third, we find that prolonged MET signaling in developing cortical neurons and slice cultures represses functional glutamatergic synapse formation and maturation. Last, mosaic genetic manipulation of MET expression in single neuron during in vivo PFC development leads to changes of intra-cortical connectivity, indicative of altered cortical information processing in a circuit highly relevant to ASD pathogenesis.
Disruptions to the molecular mechanisms controlling excitatory synapse structure and function, often seen with deleterious mutations in synaptic proteins, [46] [47] [48] [49] have been suggested to underlie neurodevelopmental disorders affecting cognition, including intellectual disability and ASD. 50, 51 Unlike many other synaptic proteins implicated in ASD, MET protein expression spans a long developmental time line and is functionally pleiotropic. Both MET mRNA and protein become abundant at late embryonic stage, and persist through early post-weaning time in mice, with precipitous downregulation thereafter. 4, 5 Therefore, peak expression of MET coincides the prime period of neurite growth, synaptogenesis and circuit formation. 52 In adult mouse brain, however, a lower levels of MET is located at both presynaptic and postsynaptic compartments, 53, 54 and is capable of modulating mature synapse function and plasticity. 55 Therefore, the impact of MET on the developing brain can be multifaceted, prolonged and profound. This is in agreement with accumulating evidence that time-delimited disruption of molecular signaling events during development can have long-term effects on brain function. 56, 57 Our study for the first time established that MET engages small GTPase Cdc42 as growth-associated mechanisms in early neuronal development. This early dendritic morphology development may be a prerequisite for later emergence of dendritic spines and synaptic signaling macromolecules, including glutamate receptors and their downstream targets. We show that MET OE is sufficient to increase dendritic complexity and spine density, a process that is blocked by Cdc42 antagonism. The fact that Cdc42 is activated downstream of MET in a PI3K-and MET kinase activitydependent manner delineates a previously unrecognized pathway operating in developing neurons and circuits. Cdc42 activation has been shown to promote dendritic protrusion and spine morphogenesis, 38, 58 and insufficient signaling through this pathway may well account for reduced spine density in CA1 neurons following MET RNAi. 24 The fact that MET is concentrated at the growth cone, and responds to HGF by activating small GTPase Cdc42, is also consistent with a recent ASD genetic study reporting an enrichment of genetic variations that disrupts 'functional gene sets involved in cellular proliferation, projection and motility, and GTPase/Ras signaling'. 59 It is unclear from the current study what downstream mechanism following MET activation may operate to suppress glutamatergic synapse maturation. These potential mechanisms may be negatively coupled with pre-and postsynaptic assembly, inhibition of AMPAR recruitment to the synapse to maintain the proportion of 'silent synapses' (Liao 1995), and suppression of GluN2B4GluN2A subunit switching with the implication of altered cortical plasticity. Therefore, normal developmental downregulation of MET signaling beyond early postnatal stage may release a developmental brake that inhibits synapse maturation. LSPS functional mapping revealed that with reduced developmental MET expression, L5 PFC neurons receive less-synaptic inputs. In comparison, enhanced MET expression leads to more synaptic connections overall, specifically from 'ectopic' laminar locations. It is unclear how MET gain-and loss-offunction in single cortical neurons may cell-autonomously affect local cortical laminar connectivity. This altered connectivity could be the combinatory effects of altered dendritic spine density, synapse maturation or activity-dependent synaptic-pruning processes, as manipulating MET in CA1 neurons also alters dendritic morphology, spine size and density, and maturation timing. 24 Nonetheless, because the topography of synaptic drive onto these cortical projection neurons is significantly changed, one can expect altered precision and specificity of cortical information processing and altered cortical output resulting from disrupted MET signaling levels.
How does alteration of a single protein cause such dramatic morphological and functional changes in neurons? The current study and previous works 13, 24, 29, 60 clearly indicate MET as a key factor for dendritic and spine development. Dendritic and spine morphology are known to be regulated by multiple growth factors and are key determinants of neurotransmitter signaling efficiency and critical constituents of circuit function. 1, 61 For instance, spine size and geometry is well correlated with its glutamate-receptor content and functional maturity. 42 A large spine head size is more mature, yet lacks the plasticity and motility of an immature spine, which more likely serves to promote initial circuit wiring and experience-shaped rewiring of neuronal circuits during development. 62 Thus, a faulty developmental program that causes earlier spine maturation may hardwire the circuits earlier and render them resistant to later phases of experience-dependent refinement. Interestingly, this 'accelerated maturation' hypothesis has been suggested in mice with haploinsufficiency of SynGAP1 (ref. 57) or overexpression of another autism-risk gene NLGN1 in mice. 63 In summary, our study provides important new insight into the role of MET-receptor tyrosine kinase in mammalian CNS development, and how dysregulation of MET signaling alters neural development and circuit function. Our study also supports the findings of a recent study that implicates an enrichment of ASD-risk genes related to growth factor signaling, 64 the hypothesized aberrant growth trajectories in the ASD brain, 65 and the coalescence of functional ASD gene networks in cortical projection neurons. 66 Although future work will be required to fully understand how loss-and gain-of MET signaling engages downstream signaling cascades impinging on the developing brain to alter the risk for ASD, we show that changes in MET expression profoundly affect neuronal structure and function, formation and maturation of excitatory synapses, and circuit connectivity in the disease-related brain regions and functional domains. The roles of MET described here may help inform how altered developmental signaling pathway give rise to cortical circuit dysfunction that potentially contribute to the development of ASD-related pathophysiology.
